O’Connor, J. M., Fessele, K. L., Steiner, J., Seidl-Rathkopf, K., Carson, K. R., Nussbaum, N. C., . . . Gross, C. P. (2018). Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials. JAMA Oncology ; volume 4, issue 8, page e180798 ; ISSN 2374-2437. https://doi.org/10.1001/jamaoncol.2018.0798
Παραπομπή σε μορφή Chicago (17η εκδ.)O’Connor, Jeremy M., et al. "Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice Vs Pivotal Clinical Trials." JAMA Oncology ; Volume 4, Issue 8, Page E180798 ; ISSN 2374-2437 2018. https://doi.org/10.1001/jamaoncol.2018.0798.
Παραπομπή σε μορφή MLA (9th εκδ.)O’Connor, Jeremy M., et al. "Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice Vs Pivotal Clinical Trials." JAMA Oncology ; Volume 4, Issue 8, Page E180798 ; ISSN 2374-2437, 2018, https://doi.org/10.1001/jamaoncol.2018.0798.